Since high Mcl-1 protein levels often coincided with high USP9x protein levels at higher stages during prostate cancer progression, a posttranslational stabilization by USP9x provides here a credible explanation for elevated Mcl-1 levels. Here, USP9X is linked to prostate carcinoma.